You are not a candidate for this specific peptide program if you or your family have a history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are currently pregnant or nursing
CJC-1295 is a peptidic growth hormone-releasing hormone (GHRH) analogue, stimulating GH production in the pituitary gland
Here's the silver lining: when you turn 65, you'll get a second Medigap Open Enrollment Period
doi: 10.1093/aje/kwu217 127 Whirl-CarrilloM.McDonaghE
Other patients may be unable to tolerate the side effects of the standard starter dose, but microdosing allows them to begin at an even lower level
Chen M, Cassidy A, Gu J, Delclos GL, Zhen F, Yang H, Hildebrandt MA , Lin J, Ye Y, Chamberlain RM, Dinney CP, Wu X